Log in

TSE:CRONCronos Group Stock Price, Forecast & News

C$9.03
-0.28 (-3.01 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
C$8.59
Now: C$9.03
C$9.06
50-Day Range
C$6.84
MA: C$8.24
C$9.71
52-Week Range
C$5.82
Now: C$9.03
C$23.67
Volume1.78 million shs
Average Volume1.19 million shs
Market CapitalizationC$3.15 billion
P/E Ratio3.33
Dividend YieldN/A
BetaN/A
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
Read More
Cronos Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.1Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.64 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone416-504-0004

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$29.18 million
Cash FlowC$4.02 per share
Book ValueC$4.92 per share

Profitability

Miscellaneous

Employees291
Market CapC$3.15 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Cronos Group (TSE:CRON) Frequently Asked Questions

How has Cronos Group's stock been impacted by COVID-19 (Coronavirus)?

Cronos Group's stock was trading at C$7.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CRON stock has increased by 21.2% and is now trading at C$9.03. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cronos Group?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cronos Group.

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Cronos Group.

What price target have analysts set for CRON?

7 brokerages have issued 1-year price targets for Cronos Group's shares. Their forecasts range from C$6.00 to C$27.00. On average, they anticipate Cronos Group's stock price to reach C$11.85 in the next twelve months. This suggests a possible upside of 31.2% from the stock's current price. View analysts' price targets for Cronos Group.

Has Cronos Group been receiving favorable news coverage?

Headlines about CRON stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cronos Group earned a news impact score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the company's share price in the next few days. View the latest news aboutCronos Group.

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), NVIDIA (NVDA), Netflix (NFLX), Tilray (TLRY), Aphria (APHA) and Walt Disney (DIS).

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)
  • Mr. David Hsu, Chief Operating Officer
  • Ms. Xiuming Shum, Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.
  • Mr. William Hilson, Chief Commercial Officer

What is Cronos Group's stock symbol?

Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group?

Shares of CRON and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately C$9.03.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of C$3.15 billion and generates C$29.18 million in revenue each year. Cronos Group employs 291 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

The company can be reached via phone at 416-504-0004.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.